Alcami: US CDMO Increasing Biostorage Capacity for Biologics Growth

Alcami is a contract development and manufacturing organization (CDMO) headquartered in North Carolina with four-decades experience advancing products through every development lifecycle stage.
Operating across five campuses across the United States that cover 738,000 square feet, Alcami caters to pharmaceutical and biotech enterprises of all scales. The CDMO offers bespoke and inventive solutions for analytical development, clinical to commercial sterile and oral solid drug product manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services.
We spoke to Timothy Compton, Chief Business Officer Alcami to explain more.
“Biologics is a growing area for us.” says Tim. “We’ve been supporting biologic products for about 20 years. We have growing capabilities within sterile fill-finish, and a 50/50 split between a traditional small molecule and biologics products.”
“We are opening a new 65,000 square foot cGMP biostorage facility in North Carolina this year. For us, it’s about maintaining scalability for our customers, we certainly don’t want to run out of run of capacity in support of the growth of our our customers programmes.”
Unmet need for downstream capacity
While there’s a tremendous amount of capacity coming online for bulk drug substance (BDS) manufacturing, Tim explains that “there is an unmet need for all the downstream activities associated with building that capacity.”
“Analytical support for the characterization or release of those bulk drug substances; sterile fill finish, drug product manufacturing of those products; the storage of materials to support the manufacturing and the BDS itself. We feel there’s a tremendous unmet need there in the industry, and one that we feel that Alcami can help fill.”
“It’s not just by adding capacity and capabilities.” says Tim. “It’s about providing a personalised  approach to customers. Everything we do is a customised approach to their needs.  We’re always pivoting to support what’s required for their programmes to be successful.”

Read the full article